Symptoms were associated with HRQOL impairments in patients recently diagnosed with colorectal or lung cancer. Additional supportive care implemented early in cancer care, regardless of cancer stage, may provide symptom relief and improve HRQOL.
The aim of this study was to assess reproducibility of the four-category Breast Imaging Reporting and Data System [BI-RADS] density measure and examine its relationship with a continuous measure of percent density.
The purpose of this study was to determine the prevalence of post-traumatic stress symptoms in a sample of cancer survivors and to investigate their association with the impact of cancer, depressive symptoms, and social support.
Multidisciplinary tumor board meetings are common in cancer care, but limited evidence is available about their benefits. We assessed the associations of tumor board participation and structure with care delivery and patient outcomes.
This study tests a theoretical model of social and structural (socioeconomic status and access to health care) and cultural factors (acculturation and fatalism) as correlates of mammography screening among Dominican Latinas.
This report shares research and analyses of claims data related to the design of a payment model for specialty oncology services for possible testing by the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services.
This report shares results of a simulation analysis of a payment model for specialty oncology services that is being developed for possible testing by the Center for Medicare and Medicaid Innovation at the Centers for Medicare and Medicaid Services.
The authors conducted a second structured expert consultation process to rate statements related to the diagnosis, management, and surveillance of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
The purpose of this study was to identify and analyze recently published cases of breast implant-associated anaplastic large cell lymphoma (ALCL), with an emphasis on diagnosis, staging, treatment, and outcomes.
Breast implant-associated anaplastic large cell lymphoma is a rare, nonaggressive cancer that can be treated by removal of the implant and surrounding capsule. Research is needed to identify risk factors; a patient registry would aid this process.